Antimalarial Drugs I Biological Background, Experimental Methods, and Drug Resistance.

Of all the parasitic diseases that beset man in the warmer parts of the world, malaria is still the major cause of morbidity and mortality. In spite of intensive efforts to interrrupt its transmission malaria still threatens over 800 million people, more than one-fifth of the world's population...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1984.
Edition:1st ed. 1984.
Series:Handbook of Experimental Pharmacology, 68 / 1
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3215898
003 MWH
005 20191024102142.0
007 cr nn 008mamaa
008 121227s1984 gw | s |||| 0|eng d
020 |a 9783642692512 
024 7 |a 10.1007/978-3-642-69251-2  |2 doi 
035 |a (DE-He213)978-3-642-69251-2 
050 4 |a E-Book 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
245 1 0 |a Antimalarial Drugs I  |h [electronic resource] :  |b Biological Background, Experimental Methods, and Drug Resistance. 
250 |a 1st ed. 1984. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 1984. 
300 |a XVIII, 484 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 68 / 1 
490 1 |a Springer eBook Collection 
505 0 |a The Malaria Parasites -- 1 Life Cycles -- 2 Metabolism -- 3 In Vitro Culture Techniques -- Host Responses to Malaria -- 4 Immunity -- 5 Clinical Pathology -- Experimental Models -- 6 In Vitro Techniques for Antimalarial Development and Evaluation -- 7 Use of Avian Malarias (In Vivo) -- Chapte 8 Rodent Malaria Models -- 9 Malaria Models in Simian Hosts -- 10 Surrogate Models for Antimalarials -- 11 Interactions Between Chemotherapy and Immunity -- Preclinical and Clinical Trial Techniques -- 12 Preclinical Testing -- 13 Clinical Trials — Phases I and -- 14 Clinical Trials — Phases III and IV and Field Trials -- 15 Pharmacogenetic Factors in Antimalarial Drug Testing -- Antimalarial Drug Resistance -- 16 History and Current Status of Drug Resistance -- 17 Evaluation of Drug Resistance in Man -- 18 Experimental Production of Drug Resistance. 
520 |a Of all the parasitic diseases that beset man in the warmer parts of the world, malaria is still the major cause of morbidity and mortality. In spite of intensive efforts to interrrupt its transmission malaria still threatens over 800 million people, more than one-fifth of the world's population. Malignant tertian malaria caused by Plasmodium Jalciparum probably kills a million every year. Vivax malaria temporarily incapacitates millions more. The search for antimalarial drugs, both natural and syn. thetic, has been and continues to be one of the most challenging and, at times, rewarding exercises ever undertaken by ;:;hemists and biologists. The magnitude of the effort is reflected by the fact that, in the last 15 years, well over 250000 compounds have been screened for antimalarial activity in just one programme, that carried out under the auspices of the Walter Reed Army Institute of Research, not to mention sporadic studies undertaken by other research workers and organisations. While most people engaged in the search for new drugs agree that a rational approach based on knowledge of the intimate biochemical pathways of the target cells would be ideal as well as intellectually satisfying, most are reluctantly obliged to concede that, up to the present time, the chances of success following a more or less empirical search have been far greater. Spectacular advances in molecular biology and biochemistry in recent years, however, are rapidly changing this situation. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Pharmacology. 
650 0 |a Medical microbiology. 
650 0 |a Pharmacy. 
690 |a Electronic resources (E-books) 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 68 / 1 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-3-642-69251-2  |3 Click to view e-book 
907 |a .b32158981  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g gw   |h 0  |i 1 
912 |a ZDB-2-SBL 
912 |a ZDB-2-BAE 
950 |a Biomedical and Life Sciences (Springer-11642) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21290635  |z 02-26-20 
999 f f |i 6359404f-f68f-50f6-8556-a08cd87d76c8  |s 08d36555-d63f-57c7-945c-40dfc0a8a56a 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |e E-Book  |h Library of Congress classification  |i Elec File  |n 1